Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.57) by 7.02 percent. The company reported quarterly sales of $8.797 million which beat the analyst consensus estimate of $8.536 million by 3.06 percent. This is a 0.62 percent decrease over sales of $8.852 million the same period last year.